The high and rising costs of anticancer drugs have received national attention. The prices of brand-name anticancer drugs often dwarf those of established generic drugs with similar efficacy. In ...
One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.
Please provide your email address to receive an email when new articles are posted on . For approval, generic fluticasone-salmeterol was required to be tested in only patients with asthma, not COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback